Indianapolis, Indiana, United States The main office of represented Corporate Investor is situated in the Indianapolis. The venture was found in North America in United States.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Indiana University Health, startups are often financed by Sanderling Ventures, River Cities Capital Funds, Triathlon Medical Venture Partners. The meaningful sponsors for the fund in investment in the same round are Triathlon Medical Venture Partners, Sanderling Ventures, River Cities Capital Funds. In the next rounds fund is usually obtained by Silicon Valley Bank, MidCap Financial.
The fund has no exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 16-20 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight PerfectServe, Endocyte. Among the most popular fund investment industries, there are Health Care, Mobile.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2015. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2011.
| Fund Name | Location |
| Carlyle Global Partners | District of Columbia, United States, Washington |
| Chilton Investment | Connecticut, Stamford, United States |
| Claytonia Capital | California, San Francisco, United States |
| Ghilotti Brothers | California, San Rafael, United States |
| Paladin Capital Group | District of Columbia, United States, Washington |
| Retinal Degeneration Fund | North Carolina, Raleigh, United States |
| Ringier | Switzerland, Zürich, Zurich |
| Starta Accelerator | New York, New York, United States |
| Yatra Angel Network | India, Maharashtra, Mumbai |
| Zhonglu Investment Management | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Endocyte | $26M | 19 Jan 2010 | Indiana, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Endocyte | $26M | 19 Jan 2010 | Indiana, United States |
